Furthermore, our subscription-based model is designed to prevent hoarding. By receiving your medication exactly when you need it, you minimize the chance of a vial sitting in your fridge long enough to expire
Meanwhile, patients on 1 mg, 1.7 mg, 2 mg and 2.4 mg injectable semaglutide had a median weight loss of 4.5%, 6%, 5.9% and 10%, respectively
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which mimics a hormone responsible for regulating appetite and stimulating insulin release
Generally well tolerated at recommended doses
Many people want safe ways to manage weight and improve their health
Dual GLP-1 & GIP therapy is among the most effective medical weight loss options available and Nexa makes it accessible without insurance hassles